A MARKET IN MOTION
Healthcare news & analysis
Explore the developments shaping healthcare markets, organizations and commercial priorities.
Browse the library ↓741 resources to explore
FEATURED / MARKET WATCH
Lawsuit Over Hospital Grades Becomes a Free-Speech Showdown
Explore the featured story ↗741 resources
Merck Licenses SciBrunch Cancer Drug in Deal Worth Up to $2.13 Billion
Read more ↗
Pennsylvania Measles Cases Cross 900 as Outbreak Grows
Read more ↗
Pfizer and Moderna Lose Bids to Escape Bayer U.S. mRNA Patent Lawsuit
Read more ↗
Robert Hunter to Become New UnitedHealthcare President
Read more ↗
U.S. Drugmakers Turn to China for New Medicines
Read more ↗
AI Tools Generated Nearly $1 Billion in Extra Costs, Blue Cross Insurers Say
Read more ↗
City Therapeutics Files for U.S. IPO as Biotech Market Remains Active
Read more ↗
FDA Approves Lilly’s Once-Weekly Insulin Injection for Type 2 Diabetes
Read more ↗
FDA Nominee Heidi Overton Faces Questions on Vaccines, Abortion Pill and Vaping
Read more ↗
Merck’s Eye Disease Drug Meets Main Goal in Late-Stage Trial
Read more ↗
Roche Signs Drug-Discovery Deal With Atavistik Bio Worth Up to $2 Billion
Read more ↗
US Packaged Food Makers Could Help Cut Diet-Related Deaths, Study Shows
Read more ↗
Arizona Sues Kratom Drink Maker Over Alleged False Advertising
Read more ↗
FDA Advisers Back Grail’s Blood-Based Cancer Test in Key Vote
Read more ↗
FDA Plans Steps to Speed Up Approvals for Vapes and Nicotine Pouches
Read more ↗
Judge Appears Open to Blocking Trump Administration Limits on HIV Funding
Read more ↗
Novartis Defeats Drug-Purchaser Lawsuit Over Delay of Entresto Generics
Read more ↗
UC San Francisco Disputes DOJ Finding That Medical School Discriminated in Admissions
Read more ↗
U.S. CDC Confirms First Measles-Related Death of 2026
Read more ↗
Wegovy Pill May Be a Strong Option for People Trying to Lose Recently Gained Weight
Read more ↗
Amgen’s Autoimmune Drug Succeeds in Late-Stage Trial
Read more ↗
U.S. Cancels Obamacare Policies Covering 760,000 People Over Suspected Fraud
Read more ↗
ADARx Pharmaceuticals Targets $1.74 Billion Valuation in U.S. IPO
Read more ↗
Grail Rallies as FDA Staff Flags No Major Concerns for Multi-Cancer Test
Read more ↗
J&J's Caplyta Meets Main Goal in Bipolar Mania Study
Read more ↗
Nvidia, QIA-Backed Iambic Therapeutics Files for U.S. IPO as Biotech Boom Rolls On
Read more ↗
Pennsylvania Measles Cases Near 800 as Outbreak Grows
Read more ↗
All 50 States to Participate in Medicaid Most-Favored-Nation Drug Pricing Program
Read more ↗
Anthropic Quietly Sets Up Biology Lab as It Ramps AI Drug Program
Read more ↗
Kennedy Names New Chair for U.S. Autism Advisory Panel
Read more ↗
Trump Says He Will Demand Some Childhood Vaccines Be Split Into Five Shots
Read more ↗
Two Hospital Systems Settle U.S. Probe Over Transgender-Care Billing for $9.5 Million
Read more ↗
U.S. CDC Works on Standard Definition for Measles Deaths as Cases Rise
Read more ↗
U.S. FDA Approves Lilly's Breast Cancer Drug Combination
Read more ↗
U.S. Weighs Allowing Most Pharma Licensing Deals With China
Read more ↗
CVS Health's Aetna to Streamline Cancer Treatment Approvals
Read more ↗
Pennsylvania Asks CDC for Help With Measles Outbreak, Demands Recognition of Deaths
Read more ↗
Pentagon to Proceed With Testosterone Testing After Pause
Read more ↗
U.S. FDA Approves Ultragenyx's Gene Therapy for Rare Disorder
Read more ↗
U.S. Health Secretary Kennedy Adds Eight New Members to Key Preventive Health Panel
Read more ↗
U.S. Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits and Risks
Read more ↗
U.S. Senate Panel Sets Hearing on Trump's FDA Pick
Read more ↗
Advil Maker Haleon Boosts U.S. Sales by Targeting Consumers on Weight-Loss Drugs
Read more ↗
CDC Delay Slows COVID Vaccine Orders for Children's Immunization Program
Read more ↗
Longeveron Explores Strategic Options After Therapy Fails Mid-Stage Trial in Infants
Read more ↗
Majority of U.S. Gen Z Healthcare Workers Eye New Jobs Within the Year
Read more ↗
Pennsylvania Measles Cases Top 700 After Four Outbreak-Related Deaths
Read more ↗
Republican Senator Faults Trump Vaccine Policy as U.S. Measles Deaths Rise
Read more ↗
Scientists Challenge U.S. NIH Grant Screening as Unconstitutional
Read more ↗
Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug
Read more ↗
Texas Abortion Ban Caused Pregnant Woman's Death, Lawsuit Claims
Read more ↗
Healthcare Software Firm Waystar Explores Options Including Sale
Read more ↗
Testosterone Prescriptions for Women Rise, Along With Denials and Delays
Read more ↗
Bristol Myers Sues Amgen Over Proposed Opdivo Biosimilar
Read more ↗
Pennsylvania Reports Two Additional Measles-Associated Deaths
Read more ↗
Legend Biotech Taps Novartis Veteran Ingrid Zhang as CEO
Read more ↗
Bayer's Monsanto Unit Urges Missouri Judge to Approve $7.25 Billion Roundup Settlement
Read more ↗
FDA Holds Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace
Read more ↗
Abbott to Pay $384 Million Over Contaminated Infant Formula Allegations
Read more ↗
Scholar Rock Prices First Drug to Target SMA Muscle Loss at $11,659 per Vial
Read more ↗
Woman Dies of Complications from Measles in Western Pennsylvania
Read more ↗
Lilly Says Foundayo Has Captured Over 30% of New U.S. Patients on Oral Weight-Loss Drugs
Read more ↗
Washington State Defeats Church's Appeal Over Healthcare Coverage for Abortion
Read more ↗
Arizona Accuses L’Oréal of Concealing Cancer Risks Linked to Hair Relaxers
Read more ↗
Tylenol Maker and Pharmacy Chains Ask U.S. Appeals Court to Revisit Decision Over Alleged Autism Link
Read more ↗
U.S. Declares End to Largest Recorded Cyclosporiasis Outbreak
Read more ↗
U.S. FDA Extends Review of Exelixis' Cancer Drug
Read more ↗
AbbVie Migraine Drug Shows Promise in Trial
Read more ↗
An Opioid Appeal Could Test the Limits of Judicial Power in Mass Torts
Read more ↗
Children of 9/11 to Finally Get a Major Health Study
Read more ↗
U.S. FDA Pauses New Enrollment in Biohaven's Epilepsy Drug Trials
Read more ↗
U.S. to Issue $500 Obamacare Refunds to Nearly 1 Million Americans
Read more ↗
TPG Explores $5 Billion Sale of Healthcare Software Company Lyric
Read more ↗
U.S. Appeals Court Skeptical of Bid to Curtail Abortion Pill Access
Read more ↗
AI Healthcare Platform Forus Valued at $3 Billion in Latest Funding Round
Read more ↗
Blackstone Explores Sale of ZO Skin Health, Valuation Could Reach $2 Billion
Read more ↗
Boston Scientific Says Cyberattack Likely to Hurt 2026 Sales and Profit
Read more ↗
Bristol Myers’ Blood Cancer Cell Therapy Meets Main Goal in Mid-Stage Trial
Read more ↗
Dyne, Sarepta Shares Tumble After Novartis Muscle-Disease Drug Trial Failure
Read more ↗
U.S. Health Department Names Permanent Heads for Key FDA Centers
Read more ↗
Cyclosporiasis Outbreak Exposes a Weakened U.S. Public Health System
Read more ↗
JPMorgan Hires Healthcare Banker David Blais From Guggenheim
Read more ↗
More U.S. Children Under 12 Are Being Prescribed Weight-Loss Drugs, Study Finds
Read more ↗
U.S. CDC Records More Than 3,100 Measles Cases So Far in 2026
Read more ↗
Cipla and Qilu Partner to Launch Keytruda Biosimilar in the U.S.
Read more ↗
Cyclosporiasis Cases in Michigan Climb to Over 14,700
Read more ↗
GoodRx Offers Family Health Subscription, Plans Employer Benefit Launch in 2027
Read more ↗
Haleon Secures Better Shelf Space at Walmart and Target to Boost U.S. Market Share
Read more ↗
Pentagon Temporarily Rescinds Guidance on Testosterone Screening for U.S. Troops
Read more ↗
Rival Lawyers Clash Over Fees After $2.8 Billion Blue Cross Settlement
Read more ↗
U.S. FDA Approves Ionis Pharma’s Therapy for Rare Brain Disorder
Read more ↗
U.S. FDA Works With Manufacturers to Increase Estradiol Patch Supply Amid Access Problems
Read more ↗
Altria Sues FDA Over U.S. Tobacco Product Review System
Read more ↗
uniQure Seeks U.S. Approval for Huntington’s Gene Therapy After FDA Reversal
Read more ↗
Oncology Firm Novocure Says Cyberattack Exposed U.S. Patient Records
Read more ↗
UnitedHealthcare to Drop Prior Authorization Requirements for a Range of Conditions from October 1
Read more ↗
U.S. Refusals of Crucial Newborn Vitamin K Shot Surge, Raising Risk of Dangerous Bleeding
Read more ↗
Trump Names Pastor Darrell Scott to Advise Administration on Tobacco Health
Read more ↗
Mead Johnson Wins U.S. Federal Bellwether Trial Over Preterm Infant Formula Enfamil
Read more ↗
Medtronic Boosts Fiscal 2027 Forecasts on Strong Heart-Device Demand
Read more ↗
U.S. States’ Lawsuit Seeking to Curb Abortion Drug Access Paused for Now
Read more ↗
U.S. Sues Kansas School District for Aiding Transgender Students’ Transitions
Read more ↗
600,000 Seniors Have Signed Up for Obesity Drugs Under New Medicare Program
Read more ↗
Eli Lilly to Buy Merida Biosciences for Up to $2.88 Billion in Autoimmune Drug Push
Read more ↗
Teladoc Appoints Insurance Executive Michael Grasher as CFO
Read more ↗
Trump Administration to Announce Drug-Pricing Deals
Read more ↗
Roivant, Priovant Launch Newly Approved Rare Disease Drug Lisraya at $35,000 a Month
Read more ↗
Walmart Settles U.S. Government's Opioid Lawsuit for $50 Million
Read more ↗
Qiagen Owes 10x, Roche $4.8 Million for Infringing Patents, U.S. Jury Says
Read more ↗
Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough
Read more ↗
Biopharma Firm BioXcel Therapeutics Files for Bankruptcy in U.S.
Read more ↗
Measles Cases in Pennsylvania Rise to 460 Amid Ongoing Outbreak
Read more ↗
U.S. FDA Approves Takeda, Protagonist's Drug for Rare Blood Cancer
Read more ↗
Kennedy Advisers Recommend Doubling U.S. Autism Spending on Care and Family Support
Read more ↗
U.S. FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
Read more ↗
U.S. FDA Approves Roivant-Priovant's Skin and Muscle Disease Drug
Read more ↗
U.S. FDA Approves Updated COVID Vaccines for 2026-27 Season
Read more ↗
U.S. States Sue to Block New Conditions for Family-Planning Grants
Read more ↗
U.S. Widens Lettuce-Related Cyclosporiasis Probe to 20 States
Read more ↗
Biohaven Licenses Epilepsy Drug to South Korea's SK Biopharmaceuticals for Up to $795 Million
Read more ↗
Boston Scientific Hit by Cyberattack, Global Operations Affected
Read more ↗
Flu Vaccine Made in Baker's Yeast Could Yield Longer Protection and Streamline Manufacturing
Read more ↗
Meta Agrees to Pay Up to $18 Billion to Settle U.S. Lawsuits Over Children's Social Media Addiction
Read more ↗
Meta, U.S. States Discussed Settling Teen Social Media Harm Case
Read more ↗
Revolution Medicines Gets FDA Approval for Targeted Pancreatic Cancer Drug
Read more ↗
U.S. Produce Supplier Taylor Farms Frequently Fails to Disclose Workplace Injury Tallies
Read more ↗
What Meta Agreed to in U.S. Teen Safety Settlement
Read more ↗
White House to Announce New Drug-Pricing Deals With Biotechs
Read more ↗
Bristol Myers Ends Blood Cancer Drug Deal With Cell Therapy Maker Cellares
Read more ↗
How the Merck-Moderna Cancer Vaccine Works and Barriers to Wide Use
Read more ↗
Instagram Head Adam Mosseri Testifies in Meta Trial Over Children's Social Media Use
Read more ↗
McKesson to Buy Precision Medicine Group for About $2.25 Billion
Read more ↗
More U.S. Employers to Drop Weight-Loss Drugs in 2027 as Healthcare Costs Increase
Read more ↗
Pennsylvania Reports Two Measles Deaths as U.S. Outbreak Grows
Read more ↗
Too Much Information, Not Enough Understanding: Opella's Push for Health Literacy
Read more ↗
U.S. Plans to Appoint Two New FDA Deputy Commissioners for Tech and Drugs
Read more ↗
What to Know About U.S. Measles Cases as They Rise
Read more ↗
Altria and Philip Morris International Sign Contract Manufacturing Deals
Read more ↗
FDA Places Clinical Hold on Regenxbio's Gene Therapy for Hunter Syndrome
Read more ↗
FDA Extends Review of Capricor's Duchenne Muscular Dystrophy Therapy
Read more ↗
U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute
Read more ↗
Roche and Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance
Read more ↗
Trump's Vaccine Order Driven by Frustration Over Autism Research
Read more ↗
Cytek Ordered to Pay Beckman Coulter $56 Million in Cell-Analysis Patent Case
Read more ↗
Fauci's Lawyers Set Up Legal Defense Fund as U.S. Probes Multiply
Read more ↗
Scholar Rock Withdraws European Filing for Muscle-Weakness Drug, Plans Resubmission
Read more ↗
Three Scientists Beat Johnson & Johnson Defamation Suit Over Talc Research
Read more ↗
Uber Defeats Bid to Dismiss Racketeering Lawsuit Against California Lawyers and Doctors
Read more ↗
U.S. Health Agencies Report 55 E. coli and Salmonella Cases Linked to Alfalfa Sprouts
Read more ↗
U.S. Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order
Read more ↗
U.S. HHS Launches Initiative to Improve Response to Missing Autistic Individuals
Read more ↗
Abbott to Pay $670 Million to Settle Some Preterm Infant Formula Cases
Read more ↗
Michigan Cyclosporiasis Cases Rise Above 14,200 as Outbreak Begins to Slow
Read more ↗
Taylor Farms Became a Salad Industry Giant Before U.S. Cyclosporiasis Outbreak
Read more ↗
U.S. Employer Healthcare Costs Expected to Rise 9.5% in 2027
Read more ↗
U.S. Appeals Court Rejects FDA Rule Requiring Graphic Cigarette Warnings
Read more ↗
Abbott Settles Appeal in $495 Million Premature Infant Formula Lawsuit
Read more ↗
CDC Reports Multistate Salmonella Outbreak Grows to 431 Cases Across 32 States
Read more ↗
Michigan Confirms First Human Case of Rare Mosquito-Borne Disease Since 2021
Read more ↗
Study Finds Refrigerated Platelets Can Be Safely Stored for Up to Three Weeks
Read more ↗
Trump Nominates White House Adviser Heidi Overton to Lead the FDA
Read more ↗
U.S. Families and Healthcare Providers Feel the Impact of Haitian Immigration Crackdown
Read more ↗
U.S. FDA Approves Regeneron's First Treatment for Rare "Second Skeleton" Bone Disorder
Read more ↗
Dodgers Owner Mark Walter's Insurer to Reduce $6.5 Billion in Related Investments Amid Federal Probe
Read more ↗
GE HealthCare Appoints William Grogan as Chief Financial Officer
Read more ↗
Centene Appoints Chris Neczypor as CFO to Navigate Medicaid and Marketplace Challenges
Read more ↗
EyePoint's Experimental Eye Disease Treatment Misses Main Goal in Late-Stage Trial
Read more ↗
Fulcrum to Merge with Slate Medicines Following Lead Drug Setback
Read more ↗
Nestlé Develops AI-Powered Nutrition Products for People Using GLP-1 Weight-Loss Drugs
Read more ↗
U.S. Kindergarten Vaccination Rates Continue to Decline as Exemptions Reach Record High
Read more ↗
FTC Launches Antitrust Investigation Into Electronic Health Records Giant Epic Systems
Read more ↗
Capricor Shares Surge After FDA Agrees to Review New Data for Duchenne Muscular Dystrophy Therapy
Read more ↗
Experimental Blood Test Detects High-Risk Precancerous Colon Lesions Before Cancer Develops
Read more ↗
U.S. Judge Rules Idaho Must Allow Abortions to Protect Women's Health
Read more ↗
U.S. Measles Cases Surpass 2,500, Highest Annual Total in More Than 35 Years
Read more ↗
Appeals Court Revives $6.7 Billion Lawsuit Against Bristol Myers Squibb Over Delayed Cancer Drug Approvals
Read more ↗
Humana and Teva Reach Agreement Ahead of Generic Drug Price-Fixing Trial
Read more ↗
Michigan Cyclosporiasis Outbreak Grows by 1,400 Cases as Officials Say New Infections Are Slowing
Read more ↗
Planned Parenthood Must Face Texas Medicaid Fraud Lawsuit, U.S. Appeals Court Rules
Read more ↗
Taylor Farms Outbreaks Expose Gaps in U.S. Oversight of Imported Produce from Mexico
Read more ↗
Trump Administration Accuses Hospitals of Improper Billing for Gender-Affirming Care for Minors
Read more ↗
U.S. FDA Approves Bristol Myers Squibb's New Blood Cancer Treatment
Read more ↗
Definium's LSD-Based Pill Significantly Reduces Anxiety in Late-Stage Clinical Trial
Read more ↗
Eli Lilly Sues Six Companies Over Alleged Illegal Sales of Experimental Obesity Drug
Read more ↗
Experts Raise Safety Concerns About Neurocrine's Rare Disease Drug for Prader-Willi Syndrome
Read more ↗
Hims & Hers Prepares Peptide Launch as Investors Temper Near-Term Growth Expectations
Read more ↗
Study Finds Wildfires Are Now the Largest Source of Harmful Air Pollution Exposure During U.S. Pregnancies
Read more ↗
Trump's Childhood Vaccine Order Reshapes Federal Recommendations as Medical Groups Raise Concerns
Read more ↗
U.S. Appeals Court Voids Key Formula Used to Resolve Surprise Medical Billing Disputes
Read more ↗
Whole Foods Recalls Products Containing Jalapeños Over Potential Salmonella Contamination
Read more ↗
U.S. Ends Federal Funding for Gender-Affirming Care for Low-Income Minors
Read more ↗
U.S. FDA Finalizes New Food Safety Guidance for Fresh-Cut Produce
Read more ↗
Bristol Myers Squibb to Invest $2.3 Billion in New Houston Manufacturing Campus
Read more ↗
Global Drugmakers Expand U.S. Manufacturing as Tariff Threats Reshape Industry Strategy
Read more ↗
Hims & Hers Raises 2026 Revenue Forecast on Strong Subscriber Growth
Read more ↗
Jazz Pharmaceuticals to Acquire Actio Biosciences in Up to $1.32 Billion Rare Epilepsy Deal
Read more ↗
RFK Jr. Unveils Plan to Close Longstanding Food Chemical Reporting Loophole
Read more ↗
Sionna Halts Development of Experimental Cystic Fibrosis Drug After Mid-Stage Trial Setback
Read more ↗
Teledyne to Acquire Varex Imaging in $1.1 Billion Medical Imaging Deal
Read more ↗
Trump Signs Executive Order Seeking More Flexibility in U.S. Childhood Vaccination Schedule
Read more ↗
UK Becomes First European Country to Approve Eli Lilly's Obesity Pill
Read more ↗
U.S. FDA Proposes Stronger Oversight of Food Additives to Increase Transparency
Read more ↗
U.S. Recommends Routine Childhood Vaccination for 11 Core Diseases Under New Federal Policy
Read more ↗
AGS Health Files Updated IPO Papers as Healthcare Revenue Cycle Management Demand Continues to Grow
Read more ↗
FDA to Hold Advisory Committee Meeting on Grail's Multi-Cancer Blood Test
Read more ↗
Multistate Salmonella Outbreak Continues to Grow Across the United States
Read more ↗
ResMed Shares Fall as Weak 2027 Sales Forecast Overshadows Quarterly Profit Beat
Read more ↗
Scholar Rock Revises FDA Filing for Muscle Weakness Drug After Removing Catalent Manufacturing Site
Read more ↗
Sweetgreen Cuts Forecast as Cyclosporiasis Outbreak Weighs on Business
Read more ↗
U.S. Tightens Travel Rules for Travelers Returning from Ebola-Affected Regions
Read more ↗
Teva Seeks to Keep Israeli Origins Out of Jury in U.S. Generic Drug Price-Fixing Trial
Read more ↗
Bayer Seeks Short Delay in $7.25 Billion Roundup Settlement Hearing
Read more ↗
CDC Reports 345 Illnesses in Salmonella Outbreak Linked to Jalapeño Peppers
Read more ↗
Chipotle Says 2026 Outlook Excludes Financial Impact of Minnesota Salmonella Outbreak
Read more ↗
CVS Health Raises 2026 Profit Forecast on Strong Pharmacy Performance
Read more ↗
Cyclosporiasis Cases in Michigan Surpass 12,000 as Foodborne Outbreak Continues
Read more ↗
McKesson Raises 2026 Profit Forecast on Strong Growth in Specialty Drug Business
Read more ↗
Solventum to Spin Off Healthcare Software Business, Raises 2026 Profit Forecast
Read more ↗
STERIS to Invest $600 Million in New North Carolina Manufacturing Facility
Read more ↗
U.S. FDA Approves Takeda's New Sleep Disorder Treatment
Read more ↗
U.S. Nearly Doubles Financial Commitment to Global Ebola Response
Read more ↗
U.S. Senate Confirms Susan Monarez as CDC Director
Read more ↗
Wall Street Shifts Toward Healthcare Stocks as Technology Sector Loses Momentum
Read more ↗
DaVita Reaffirms Annual Forecast Despite Lower Revenue Per Dialysis Treatment
Read more ↗
Amgen Reports Strong Second-Quarter Results as Sales and Profit Exceed Expectations
Read more ↗
BioNTech Lowers 2026 Sales Outlook as COVID-19 Vaccine Demand Continues to Decline
Read more ↗
CDC Expands Largest Known Cyclospora Outbreak to 15 States
Read more ↗
Chipotle Removes Jalapeños Linked to Minnesota Salmonella Outbreak
Read more ↗
Cyclosporiasis Cases in Michigan Rise to 11,508 as Outbreak Continues
Read more ↗
Fresenius Medical Care Shares Fall Despite Earnings Beat as U.S. Dialysis Treatment Volumes Disappoint
Read more ↗
FTC Reviews Cencora's Proposed Acquisition of Covetrus' Animal Health Business
Read more ↗
Gilead Reports Strong Second-Quarter Results as Sales Beat Wall Street Expectations
Read more ↗
Jury Orders Medtronic to Pay $88 Million in First Hernia Mesh Trial Over Covidien Products
Read more ↗
Merck Beats Second-Quarter Expectations on Strong Keytruda Sales
Read more ↗
Moderna Begins First Human Trial of Experimental Bundibugyo Ebola Vaccine
Read more ↗
Novo Nordisk Raises 2026 Outlook After Strong Second-Quarter Performance
Read more ↗
Pathos AI Licenses Experimental Breast Cancer Drug to Expand AI-Driven Oncology Pipeline
Read more ↗
Pfizer Beats Quarterly Profit Estimates on Strong Demand for Eliquis
Read more ↗
Procter & Gamble to Acquire Supplements Maker Thorne, Expanding Health and Wellness Portfolio
Read more ↗
Biotech IPO Market Rebounds as Latigo and BlossomHill Launch U.S. Public Offerings
Read more ↗
California Supreme Court Rules Drugmakers Do Not Have a Legal Duty to Develop Safer Medicines
Read more ↗
Curium to Acquire Lantheus in Up to $8 Billion Deal, Expanding Its Radiopharmaceutical Business
Read more ↗
Eli Lilly Launches Early Access Program for Next-Generation Obesity Drug
Read more ↗
Fresenius Medical Care Beats Quarterly Profit Estimates, Maintains 2026 Outlook
Read more ↗
KKR to Acquire Medical Device Manufacturer Integer Holdings in $5.7 Billion Deal
Read more ↗
Michigan Reports Two Deaths in Ongoing Cyclosporiasis Outbreak
Read more ↗
Single Measles Outbreak Can Cost Millions of Dollars, Study Finds
Read more ↗
Supernus and Indivior to Merge, Creating a Larger Neuroscience Drug Company
Read more ↗
Trump Administration Faces Lawsuit Over Ban on Gender-Affirming Care Coverage for Federal Workers
Read more ↗
Vertex Raises 2026 Revenue Forecast as Strong Demand for Cystic Fibrosis Drugs Continues
Read more ↗
AbbVie Lowers 2026 Profit Forecast Following Apogee Acquisition Despite Strong Quarterly Results
Read more ↗
Amgen Discloses Data Breach After Patient Information Is Stolen
Read more ↗
Cyclosporiasis Cases in Michigan Continue Rising as Foodborne Outbreak Expands
Read more ↗
Experimental Drug Helps Advanced Bladder Cancer Patients Avoid Bladder Removal Surgery
Read more ↗
KKR Moves Closer to Acquiring Medical Device Manufacturer Integer Holdings
Read more ↗
Moderna Misses Revenue Expectations as Weak COVID-19 Vaccine Demand Continues
Read more ↗
Novo Nordisk's Experimental Inflammation Drug Fails to Reduce Cardiovascular Risk in Late-Stage Trial
Read more ↗
Replimune Shares Rise After FDA Advisory Panel Supports Experimental Skin Cancer Therapy
Read more ↗
FDA Advisory Panel Supports Replimune's Skin Cancer Drug Data, Moving Therapy Closer to Potential Approval
Read more ↗
Labcorp Raises Annual Profit Forecast as Strong Demand for Diagnostic Testing Continues
Read more ↗
Michigan Reports More Than 10,000 Cyclosporiasis Cases as Foodborne Outbreak Continues
Read more ↗
Pfizer's Oral Vitiligo Drug Shows Strong Phase 3 Results, Moving Closer to Approval
Read more ↗
Biogen Beats Quarterly Expectations as Newer Medicines Drive Return to Growth
Read more ↗
Chipotle Raises Annual Sales Forecast as Consumer Demand Remains Strong
Read more ↗
Cyclosporiasis Cases Surpass 10,000 as Foodborne Outbreak Continues to Grow
Read more ↗
Cyclosporiasis Outbreak Begins Affecting Restaurant Sales as Consumer Confidence Declines
Read more ↗
Fauci to Testify Before Senate Committee Following Release of COVID-Era Diaries
Read more ↗
FDA Advisory Panel Votes Against Capricor's Duchenne Muscular Dystrophy Heart Therapy
Read more ↗
FDA Approves First Freeze-Dried Plasma Product, Strengthening Emergency Blood Care
Read more ↗
FTC Sues Hims & Hers Over Alleged Sharing of Users' Health Information with Meta and Snap
Read more ↗
GE HealthCare Beats Quarterly Profit Expectations as Imaging Business Drives Growth
Read more ↗
Humana Beats Quarterly Profit Expectations as Medical Costs Remain Stable
Read more ↗
Johnson & Johnson Lowers 2026 Profit Forecast Despite Strong Pharmaceutical Growth
Read more ↗
Lawmakers Press Health Secretary Robert F. Kennedy Jr. Over Vaccine Settlement Agreement
Read more ↗
MannKind's New Injection Shows Promise in Helping Heart Failure Patients Avoid Hospital Infusions
Read more ↗
Processa Acquires Vidya Therapeutics to Expand Immunology Pipeline and Fund Clinical Development
Read more ↗
Trump Administration Restores $600 Million in Funding for Global Vaccine Alliance Gavi
Read more ↗
UK Leaders Urge Social Care Reform Before Expanding Assisted Dying Debate
Read more ↗
Altimmune's Experimental Drug Shows Positive Mid-Stage Results for Alcohol Use Disorder
Read more ↗
Centene Raises 2026 Profit Forecast as Better Medical Cost Control Strengthens Performance
Read more ↗
Court-Appointed Monitor Finds Serious Deficiencies in Medical Care at California's Largest ICE Detention Facility
Read more ↗FDA Reviewers Raise Questions About Replimune's Experimental Skin Cancer Therapy Ahead of Advisory Meeting
Read more ↗
Incyte Raises 2026 Revenue Forecast After Reaching CMS Settlement
Read more ↗
IQVIA Raises 2026 Profit Forecast as Demand for Clinical Research and Healthcare Analytics Grows
Read more ↗
Novo Nordisk Must Face U.S. Shareholder Lawsuit Over CagriSema Clinical Trial Disclosures
Read more ↗
Trump Administration Plans to End Medicare Part D Subsidy Programme, Potentially Raising Drug Plan Premiums
Read more ↗
Apnimed Targets $608 Million IPO as Interest Grows in Sleep Apnoea Treatments
Read more ↗
Argenx to Acquire Forte Biosciences in $2.2 Billion Deal to Strengthen Immunology Pipeline
Read more ↗
AstraZeneca Adapts Drug Pricing Strategy as U.S. Pricing Policy Reshapes Global Market
Read more ↗
Boston Scientific Announces Restructuring Plan to Improve Efficiency and Expects Workforce Reductions
Read more ↗
FDA Approves Freenome's Blood Test for Colorectal Cancer Screening
Read more ↗
FDA Reviewers Raise Concerns Over Capricor's Duchenne Muscular Dystrophy Therapy
Read more ↗
Former FDA Commissioner Warns Cyclospora Outbreak May Extend Beyond U.S. Border
Read more ↗
Hedge Funds Increase Bets on U.S. Healthcare Stocks as Confidence in the Sector Grows
Read more ↗
Universal Health Services Lowers 2026 Outlook Amid Medicaid Reimbursement Uncertainty
Read more ↗
Abbott Wins Dismissal of Shareholder Lawsuit Tied to 2022 Infant Formula Recall
Read more ↗
Amgen Submits New Evidence to Defend Tavneos as FDA Considers Withdrawing Approval
Read more ↗
CDC Links Four Additional States to Growing Cyclospora Outbreak Investigation
Read more ↗
Experimental GLP-1 Therapy Shows Liver Benefits Beyond Weight Loss in Mid-Stage Trial
Read more ↗
FDA Advisers Consider Broader Access to Three Additional Peptides Amid Growing Demand for Personalized Therapies
Read more ↗
FDA Advisory Panel Recommends Adding Semax to Pharmacy Compounding List
Read more ↗
FDA Advisory Panel Votes Against Adding Emideltide to Pharmacy Compounding List
Read more ↗
FDA Approves First Over-the-Counter Combination Tylenol Pill for Pain Relief
Read more ↗
FDA Approves Outlook Therapeutics' Eye Drug, Introducing the First FDA-Approved Ophthalmic Bevacizumab for Wet AMD
Read more ↗
Federal Judge Orders FDA to Reconsider Restrictions on Prescribing Abortion Pill Mifepristone
Read more ↗
Mexican Authorities Find No Cyclospora in Taylor Farms Lettuce Samples as U.S. Outbreak Investigation Continues
Read more ↗
Nestlé Pushes Simpler U.S. Food Labels to Move Away from "Frankenstein Ingredients"
Read more ↗
Novo Nordisk Seeks Court Order to Block Eli Lilly Weight-Loss Drug Advertisements
Read more ↗
U.S. Measles Cases Reach Highest Level Since 1991 as CDC Reports More Than 2,300 Infections
Read more ↗
AdaptHealth Expands Home Medical Supply Reach Through Exclusive Distribution Partnership with Cardinal Health
Read more ↗
BeOne Invests $300 Million to Expand U.S. Manufacturing, Strengthening Domestic Biopharmaceutical Production
Read more ↗
Cardinal Health and AdaptHealth Expand Home Healthcare Access Through New Distribution Partnership
Read more ↗Cigna Says AI Has Saved Customers $200 Million in Medical Costs While Expanding Personalized Care
Read more ↗
Edwards Lifesciences Tops Quarterly Expectations as Heart Device Demand Accelerates
Read more ↗
Eli Lilly Reports New Positive Data for Next-Generation Obesity Drug Ahead of Planned FDA Filing
Read more ↗
FDA Advisory Panel Recommends Adding BPC-157 to Compounding List
Read more ↗
FDA Advisory Panel Recommends Placing TB-500 on Compounding List
Read more ↗
FDA Weighs Broader Restrictions on Peptides as Industry Pushes for Expanded Compounding Access
Read more ↗
GE HealthCare Announces CFO Transition While Reaffirming Strong Business Momentum
Read more ↗
Michigan Reports More Than 7,600 Cyclospora Cases as Foodborne Outbreak Continues
Read more ↗
Molina Healthcare Shares Fall as Medicaid and ACA Enrollment Concerns Weigh on Outlook
Read more ↗
Quest Diagnostics Raises 2026 Outlook as Diagnostic Testing Demand Remains Strong
Read more ↗
Senate Health Committee Chair Signals Support for Trump's CDC Director Nominee
Read more ↗
Texas Appeals Court Dismisses State's Abortion Case Against Midwife, Citing Legal Deficiencies
Read more ↗
Thermo Fisher Scientific Beats Quarterly Estimates as Research and Biopharma Demand Rebounds
Read more ↗
West Pharmaceutical Raises Annual Profit Forecast as Demand for Injectable Drug Components Continues to Grow
Read more ↗
Biotech Industry Calls for Science-Based FDA Drug Reviews Amid Agency Rebuilding Efforts
Read more ↗
FDA Advisory Panel to Review Popular Peptides as Consumer Demand Continues to Grow
Read more ↗
Former Australia Captain's Probable CTE Diagnosis Renews Focus on Brain Health in Sports
Read more ↗
Johnson & Johnson's Next-Generation Robotic Surgery System Receives FDA Marketing Authorization
Read more ↗
New Heart Disease Guidelines Could Lead Millions More Americans to Take Statins, Study Finds
Read more ↗
Obesity Drug Injections Gain Momentum as More Patients Choose Long-Term Treatment
Read more ↗
Repligen to Acquire BioLife Solutions in $1.5 Billion Deal to Expand Cell Therapy Business
Read more ↗
Sandoz Seeks Dialogue With U.S. After Proposed Tariffs on Generic Drugs Raise Industry Concerns
Read more ↗
Taco Bell Cyclospora Outbreak Weighs on Sales, but Analysts Expect a Temporary Impact
Read more ↗U.S. Launches $5 Billion AI Initiative to Accelerate Health Research and Drug Discovery
Read more ↗
Amgen Settles Shareholder Lawsuit Over Alleged Failure to Disclose $10.7 Billion Tax Liability
Read more ↗
Gilead and Merck's Weekly HIV Pill Successfully Suppresses Virus in Late-Stage Clinical Trials
Read more ↗
Mexico Says There Is No Evidence Its Lettuce Caused U.S. Cyclospora Outbreak as Investigation Continues
Read more ↗
Michigan Reports More Than 6,500 Cyclospora Cases as State Faces Largest Outbreak in Years
Read more ↗
Study Finds U.S. Aid Cuts Led to Fewer Children Receiving HIV Treatment Worldwide
Read more ↗
Trump Administration Pauses Over $1 Billion in Medicaid Payments to California and Minnesota Pending Fraud Review
Read more ↗
Trump Delays Tariffs on Generic Drugs for Two Years Before Introducing 100% and 200% Import Duties
Read more ↗
U.S. Cyclosporiasis Cases Surpass 4,100 as CDC Investigates Expanding Lettuce-Linked Outbreak
Read more ↗
U.S. Launches Pilot Program to Strengthen Domestic Production of Veterinary Medicines
Read more ↗
Bristol Myers Squibb Becomes First Drugmaker to Deploy NVIDIA's Latest AI Supercomputer for Drug Discovery
Read more ↗
FDA Says Taylor Farms Cyclospora Test Was a False Positive, but Investigation Continues
Read more ↗
Samsung Biologics Launches $1.8 Billion Bid for PolyPeptide to Strengthen Peptide Drug Manufacturing
Read more ↗
Tempus to Acquire Personalis in $1.5 Billion Deal to Expand AI-Driven Precision Oncology
Read more ↗
Abbott Investigates Two Cyber Incidents, Says Patient Care and Operations Remain Unaffected
Read more ↗
Clover Health Investigates Cybersecurity Incident After Employee Accounts Are Compromised
Read more ↗
Foodborne Illness Outbreaks Continue to Challenge U.S. Restaurant Industry
Read more ↗
Intuitive Surgical Shares Fall as Insurance Changes Renew Debate Over Medical Device Demand
Read more ↗
Michigan Reports 5,002 Cyclosporiasis Cases as Officials Intensify Search for Outbreak Source
Read more ↗
Novo Nordisk to Launch Lower-Cost Ozempic in South Africa, Expanding Access to Diabetes Care
Read more ↗
Seven American Aid Workers Quarantined in Kenya as U.S. Tightens Ebola Travel Measures
Read more ↗
Taco Bell Removes Lettuce in Several States as Cyclospora Investigation Continues
Read more ↗
Wendy's and Chipotle Say They Are Not Affected by Cyclospora Outbreak Under Investigation
Read more ↗
Abbott Raises 2026 Profit Forecast as Heart Devices and Cancer Diagnostics Drive Strong Growth
Read more ↗
AtaiBeckley Shares Surge on Reports of Eli Lilly Acquisition, Highlighting Growing Momentum in Psychedelic Medicine
Read more ↗
Eli Lilly Enters the Psychedelic Medicine Race with Up to $3.8 Billion AtaiBeckley Acquisition
Read more ↗
FDA Approves Merck's Once-Daily Cholesterol Pill, Expanding Treatment Options for Patients with High LDL
Read more ↗
Kalshi Expands Prediction Markets to Clinical Trials and FDA Decisions, Raising New Questions for Healthcare
Read more ↗
Michigan Cyclosporiasis Cases Surpass 4,000 as Health Officials Urge Food Safety and Early Diagnosis
Read more ↗
Pentagon Announces Testosterone Screening Initiative for U.S. Troops, Expanding Focus on Military Health
Read more ↗
UnitedHealth Raises 2026 Forecast as Lower Medical Costs Fuel Stronger-Than-Expected Earnings
Read more ↗
Wildfire Smoke Poses Serious Health Risks as Experts Warn of Growing Public Health Threat
Read more ↗
Elevance Health Raises Annual Profit Forecast on Improved Medical Cost Management
Read more ↗
Aetna Says Simpler Prior Authorizations and Digital Tools Can Help Rebuild Trust in Health Insurance
Read more ↗
Celcuity Shares Fall Despite First FDA Approval as Delayed Breast Cancer Drug Launch Weighs on Outlook
Read more ↗
Johnson & Johnson Beats Quarterly Earnings Estimates as Medicines Business Drives Strong Growth
Read more ↗
Medtronic Faces First U.S. Trial Over Hernia Mesh Injury Claims
Read more ↗
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options
Read more ↗
Sanofi Sues Pfizer and Moderna Over COVID-19 Vaccine Technology Patents
Read more ↗
Trump's Nominee for CDC Director Faces Senate Questions on Public Health Priorities
Read more ↗
U.S. Requires Americans Returning from Congo to Wait 21 Days Before Entering Following Ebola Exposure Risk
Read more ↗
CDC Reports U.S. Cyclosporiasis Cases Surpass 1,600, Expects Total to Continue Rising
Read more ↗
CVS Reaches FTC Settlement to Count TrumpRx Drug Purchases Toward Insurance Deductibles
Read more ↗
FDA Sued Over Decision to Allow Unauthorized Vaping Products to Remain on the U.S. Market
Read more ↗
HCA Reports Preliminary Quarterly Revenue Above Expectations as Demand for Hospital Care Remains Strong
Read more ↗
IVF Lawsuits Increase as Courts Confront New Legal Questions Around Fertility Care
Read more ↗
Michigan Cyclosporiasis Cases Surpass 3,000 as Outbreak Continues to Grow
Read more ↗
RFK Jr.'s Vaccine Policy Changes Could Reshape U.S. Immunization Strategy
Read more ↗
U.S. Government Rescinds $10 Billion Funding Freeze Affecting Five Democratic-Led States
Read more ↗
U.S. Health Authorities Investigate Taco Bell Following Reports of Foodborne Illness
Read more ↗
U.S. Restricts Immediate Return of Americans in Congo Following Ebola Exposure Risk
Read more ↗
Albertsons Accused of Overworking Pharmacists, Contributing to the Opioid Crisis in Washington
Read more ↗
Cyclosporiasis Outbreak Raises Public Health Concerns Across the United States
Read more ↗
FDA Approves At-Home Starter Dose for Eisai and Biogen's Alzheimer's Drug Leqembi
Read more ↗
FDA Urges Infant Formula Manufacturers to Strengthen Supplier Oversight Following Product Recall
Read more ↗
German Hospital Treats American Ebola Patient Infected During Congo Outbreak
Read more ↗
HHS Watchdog Expects $5.56 Billion in Recoveries and Savings from Fraud Investigations and Audits
Read more ↗
Michigan Cyclosporiasis Cases Surge Past 2,600 as State Investigates Ongoing Outbreak
Read more ↗
U.S. Appeals Court Revives Lawsuits Alleging Tylenol Use During Pregnancy Caused Autism and ADHD
Read more ↗
FDA Approves Sanofi's Wearable Injector for Blood Cancer Drug Sarclisa, Expanding Treatment Options
Read more ↗
FDA Declines to Approve Elevar Therapeutics' Liver Cancer Drug Combination Over Manufacturing Issues
Read more ↗
FDA Proposes New Rule to Simplify Registration Requirements for Certain Drug Manufacturers
Read more ↗
Judge Allows FTC Case Against Transgender Health Nonprofit to Move Forward
Read more ↗
Lung Transplant May Offer a Lifesaving Option for Select Patients with Advanced Lung Cancer, Study Finds
Read more ↗
U.S. Citizen in Congo Tests Positive for Ebola, CDC Says No Risk to the American Public
Read more ↗
Warburg Pincus Nears $7 Billion Acquisition of Rare Disease Drugmaker PanTheryx Rare
Read more ↗
California Judge Says State Cannot Seek Damages from 23andMe's Successor Over 2023 Data Breach
Read more ↗
U.S. Appeals Court Upholds AstraZeneca Victory in Cancer Drug Patent Dispute with Pfizer
Read more ↗
New York Sues 3M, DuPont and Other Companies Over PFAS 'Forever Chemicals' in Consumer Products
Read more ↗
Obamacare Insurers Seek Second-Largest Premium Increase in Nearly a Decade for 2027 Plans
Read more ↗
Trump's CDC Director Nominee Prepares for Senate Confirmation Hearing
Read more ↗
Federal Appeals Court Allows Florida to Continue Lawsuit Over Transgender Youth Care Guidelines
Read more ↗
Newer-Style Hip Implant Significantly Reduces Risk of Dislocation After Replacement Surgery, Study Finds
Read more ↗
Kailera's Oral GLP-1 Drug Meets Late-Stage Trial Goals but High Side Effects Temper Enthusiasm
Read more ↗
Obesity Drug Developer Kalohexis Confidentially Files for U.S. IPO Amid Booming GLP-1 Market
Read more ↗
ResMed Sells MatrixCare Software Business for $490 Million to Focus on Core Digital Health Strategy
Read more ↗
Sino Biopharmaceutical and AstraZeneca Sign Respiratory Drug Deal Worth Up to $5.3 Billion
Read more ↗
UnitedHealth Says Most Home Health Diagnoses Were Supported After Internal Review
Read more ↗
Former NFL Player Marshawn Kneeland Diagnosed with CTE, Renewing Focus on Long-Term Brain Injury in Contact Sports
Read more ↗
Novartis to Acquire Myricx Bio for Up to $1.5 Billion to Strengthen Its Next-Generation Cancer Drug Pipeline
Read more ↗Cigna Invests $100 Million in AI-Powered Specialty Pharmacy Program to Improve Care for Complex Diseases
Read more ↗
FDA Approves Orca Bio's Cell Therapy for Blood Cancer, Offering a New Transplant Option
Read more ↗
Judge Blocks Colorado's First-in-the-Nation Price Cap on Amgen's Enbrel
Read more ↗
Kroger to Acquire Giant Eagle for $1.65 Billion, Expanding Its Retail Pharmacy and Healthcare Footprint
Read more ↗
LSD Therapy Developer Definium Defeats Trade Secret Lawsuit, Clearing a Legal Hurdle for Its Depression Drug Program
Read more ↗
Nestlé Expects Some Parents Will Not Return After Infant Formula Recall
Read more ↗
Older Americans Expected to Flock to Medicare's New $50 GLP-1 Weight-Loss Drug Program
Read more ↗
Older Cancer Drug Shows Promise in Restoring Fertility for Certain Women
Read more ↗
Trump Administration Cuts Federal Funding for New York's Medicaid Fraud Unit
Read more ↗
Who Qualifies for Medicare's New $50 Weight-Loss Drug Program, and What Are the Challenges?
Read more ↗
AlzeCure Signs Licensing Deal Worth More Than $2.2 Billion to Advance Alzheimer's Drug Development
Read more ↗
FDA May Allow ZYN Nicotine Pouches to Be Marketed as Less Harmful Than Cigarettes
Read more ↗
Group That Won Lawsuit Over COVID-19 Vaccine Records Seeks FDA to Pay Legal Fees
Read more ↗
Medical Journal Retracts Amgen Tavneos Clinical Trial Paper Following FDA Findings
Read more ↗
Natera and Aveta Biomics Partner on Late-Stage Head and Neck Cancer Trial
Read more ↗
Roche Launches New Gene Sequencer to Challenge Illumina's Dominance in DNA Sequencing
Read more ↗
Zymeworks and Theravance Biopharma Sign Up to $929 Million Cancer Drug Development Deal
Read more ↗
FDA to Review Sandoz's Generic GLP-1 Drugs, Potentially Expanding Competition in the Obesity Market
Read more ↗
Average Launch Prices for New U.S. Drugs Fell in 2025 as Fewer Gene Therapies Reached the Market
Read more ↗
Hims & Hers Could Benefit as Employers Drop Coverage for Weight-Loss Drugs
Read more ↗
Novo Nordisk Pushes for Broader Insurance Coverage of Weight-Loss Drugs in the U.S.
Read more ↗
U.S. Supreme Court Makes It Harder for Many Roundup Cancer Lawsuits to Move Forward
Read more ↗
U.S. Military Requires Flu Vaccination for Some Personnel Following Outbreak at Texas Training Center
Read more ↗
Abbott and Alzpath Partner to Advance Blood Test for Alzheimer's Disease Detection
Read more ↗
CDC Ends Hantavirus Response After Monitoring Exposed Travelers, Report Says
Read more ↗
China Could Approve Lilly's Oral GLP-1 Weight-Loss Pill as Early as 2026, Executive Says
Read more ↗
Experimental Drug to Prevent Organ Rejection After Kidney Transplant Outperforms Standard Treatment
Read more ↗
FDA Says Hiring Is Accelerating as Agency Works to Fill More Than 2,000 Positions
Read more ↗
Ollin Raises $330 Million to Advance Late-Stage Eye Disease Drug Trials
Read more ↗
Pfizer Dismissed from Multi-State Drug Price-Fixing Lawsuit
Read more ↗
Trump Administration Seeks More Than $1.4 Billion in Emergency Ebola Funding from Congress
Read more ↗
U.S. Judge Blocks DOJ From Obtaining Transgender Care Records From New York Hospitals
Read more ↗
BIO CEO Calls for Greater Consistency in FDA Drug Review Process
Read more ↗
Extreme Heat Poses Growing Health Risks Across the United States, Experts Warn
Read more ↗
Federal Judge Blocks Trump Administration's SNAP Restrictions on Soda and Candy Purchases
Read more ↗
Lilly Says Trump's Drug Pricing Policy Could Affect Future Obesity Drug Launches in Europe
Read more ↗
Missouri Appeals Court Refuses Abbott's Request to Transfer $495 Million Preterm Baby Formula Case
Read more ↗
Pfizer Executive Says China Is Outpacing Europe in Drug Innovation and Development
Read more ↗
Shopify to Ban Vape Sales as U.S. Authorities Intensify Crackdown on Illegal E-Cigarette Market
Read more ↗
U.S. Provides Ebola Treatment in Congo, Bringing Clinical Trials Closer to Real-World Use
Read more ↗
All U.S. Passengers from Hantavirus-Affected Cruise Ship Have Returned Home, Health Officials Say
Read more ↗
China Is Closing the Gap, but the U.S. Still Leads in Biotech Innovation, Survey Finds
Read more ↗
Definium's LSD-Based Pill Reduces Depression Symptoms in Late-Stage Clinical Trial
Read more ↗
FDA Aligns with REGENXBIO on Path Forward for Rare Disease Gene Therapy
Read more ↗
FDA Declines to Approve Achieve Life Sciences' Smoking Cessation Drug
Read more ↗
FDA Updates Guidance to Help Speed Up Drug Development
Read more ↗
Nuvectis Gains Rights to Two Experimental Cancer Drugs Through Licensing Deal with China's Haisco
Read more ↗
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
Read more ↗
CDC Nominee Erica Schwartz Agrees to Divest Healthcare Holdings and Leave UnitedHealth Role if Confirmed
Read more ↗
Experimental First-in-Class Heart Drug May Also Help Heal Damaged Kidneys
Read more ↗
Merck's Pneumococcal Vaccine Wins U.S. Approval for High-Risk Children and Teenagers
Read more ↗
Pfizer CFO Dave Denton to Step Down in August
Read more ↗
Trump Administration Asks Appeals Court to Allow Kennedy's Vaccine Panel Appointments
Read more ↗
U.S. Health Department Proposes Testosterone Therapy Label Updates
Read more ↗
CDC Activates $107 Million in Emergency Funding for Ebola Response
Read more ↗
FDA Advisers Vote in Favor of Moderna's Flu Vaccine
Read more ↗
FTC Requires Aurobindo Pharma to Divest Four Drug Products to Complete Acquisition
Read more ↗
Biogen to Acquire RayThera in Deal Worth Up to $1 Billion
Read more ↗
Jazz Pharmaceuticals and AbCellera Sign Antibody Discovery Deal Worth Up to $876 Million
Read more ↗
Progesterone Supplies Tighten as Demand for Menopause Treatments Continues to Grow
Read more ↗
Robots Improve Drug Testing by Detecting Hidden Cancer Cells Researchers Often Miss
Read more ↗
uniQure Receives FDA Guidance to Pursue Approval for Huntington’s Gene Therapy
Read more ↗U.S. Health Department Announces More Than $700 Million to Combat Mental Health and Addiction
Read more ↗
FDA Staff Says Data May Support Moderna's Flu Vaccine for Older Adults
Read more ↗
Adaptive Biotechnologies Plans Separation of Immune Medicine Platform
Read more ↗
Baby Formula Maker Nara Issues Nationwide Recall After Infant Botulism Concerns
Read more ↗
Centene Offers Staff Buyouts After Obamacare Membership Losses
Read more ↗
Ebola Risk at the 2026 World Cup Is Extremely Low, U.S. Experts Say
Read more ↗
Elicio Shares Tumble After Pancreatic Cancer Therapy Misses Mid-Stage Trial Goal
Read more ↗
Mead Johnson Wins New Trial After Court Reverses $60 Million Premature Infant Formula Verdict
Read more ↗
Amgen Orders Independent Review of Tavneos Data
Read more ↗
CMS Proposes Rule for Future Medicare Drug Price Negotiations
Read more ↗
Express Scripts Challenges Tennessee Prescription Drug Law
Read more ↗
FDA Approves Sanofi's Drug for Stage 3 Type 1 Diabetes in Children
Read more ↗
FDA Clears First Over-the-Counter Glucose Monitor for Children
Read more ↗
Jazz Pharmaceuticals Lung Cancer Drug Misses Main Trial Goal
Read more ↗
Novartis Reports Promising Early Results for Rare Muscle Disease Drug
Read more ↗
United States Commits Additional $50 Million to Ebola Response
Read more ↗
Takeda's AI-Designed Psoriasis Pill Outperforms Bristol Myers Drug in Study
Read more ↗
Camurus Hormone Disorder Drug Faces Another FDA Delay
Read more ↗
FDA Grants Emergency Approval for Over-the-Counter Screwworm Treatment for Pets
Read more ↗
FDA Issues Import Alert for Drugs Manufactured at Dabur India Facility
Read more ↗
GSK Rebuilds Cancer Pipeline With $11 Billion Nuvalent Deal
Read more ↗
Heart Drug Developer Kardigan Targets $1.4 Billion Valuation in U.S. IPO
Read more ↗
Novo Nordisk Investigates Cyber Incident and Possible Data Breach
Read more ↗
PharmaSource Says It Did Not Know Dexcom Sensors Were Intended for Destruction
Read more ↗
Rising Screwworm Cases Put Federal Preparedness Efforts to the Test
Read more ↗
Some U.S. Employers Plan to Drop Coverage for GLP-1 Obesity Drugs
Read more ↗
Judge Rejects Nationwide Attempt to Block DOJ Transgender-Care Subpoenas
Read more ↗
Novo Nordisk Battles South African Compounder Over Weight-Loss Drug Copies
Read more ↗
Older Drug Appears to Improve Blood Sugar Control in Type 1 Diabetes
Read more ↗
Organon Wins FDA Approval to Expand Use of Arthritis Biosimilar
Read more ↗
U.S. Doctor Released After Ebola Monitoring in Czech Republic
Read more ↗
ICE Detention Center in Texas Criticized Over Medical Care and Missing Records
Read more ↗
mRNA Cancer Vaccines Continue Advancing Despite Federal Funding Cuts
Read more ↗
NIH Appoints Acting Leader of Major Infectious Disease Institute
Read more ↗
Parabilis Medicines Increases IPO Target to $633 Million
Read more ↗
Philips Says AI Is Improving Clinical Accuracy
Read more ↗
Previously Shelved Alcohol Study Finds Independent Publication
Read more ↗
Samsung Invests $175 Million in Genomics Company Element Biosciences
Read more ↗
Survey Finds AI Saves Clinicians Time, But Most Lack Training
Read more ↗
FDA Approves First New Sunscreen Ingredient in Decades
Read more ↗
Health Experts Plan to Monitor World Cup Wastewater for Disease Outbreaks
Read more ↗
Johnson & Johnson to Acquire Firefly Bio for $1 Billion
Read more ↗
Nineteen More Medical Schools Commit to Nutrition Training
Read more ↗
USDA Confirms Two Additional Screwworm Cases in the United States
Read more ↗
Early Pregnancy Use of GLP-1 Drugs Should Not Cause Immediate Alarm, Study Suggests
Read more ↗
FDA Approves Pfizer's Bleeding Disorder Drug for Children
Read more ↗
Gavi Plans to Use U.S. Funding for Malaria Programs While Meeting New Conditions
Read more ↗
CDC Warns Current Ebola Outbreak Could Resemble the 2014 Crisis
Read more ↗
Johnson & Johnson Wins Trial Over Talc Cancer Claims
Read more ↗
Judge Refers DOJ Lawyers for Possible Discipline in Transgender-Care Records Fight
Read more ↗
Second Screwworm Parasite Case Confirmed in Texas
Read more ↗
Structure Therapeutics Says Experimental Obesity Pill Shows No Signs of Liver Injury
Read more ↗
U.S. Experts Arrive in Kenya Despite Legal Challenges to Ebola Facility
Read more ↗
U.S. Provides Nearly $38 Million More for Ebola Response
Read more ↗
U.S. Treatment Centers Say They Are Ready for Ebola Patients
Read more ↗
Abbott Must Face Lawsuit Over PediaSure Growth Claims
Read more ↗
LaserAway Explores Potential Sale
Read more ↗
New Federal Fraud Initiative Raises Risks for Healthcare Companies
Read more ↗
Parabilis Medicines Seeks Up to $475 Million in U.S. IPO
Read more ↗
Trump Administration Cuts Funding to Hawaii Medicaid Fraud Unit
Read more ↗
U.S. Senators Question Tobacco Industry Lobbying After FDA Policy Changes
Read more ↗
U.S. Supreme Court Backs Generic Drugmaker in Major Patent Case
Read more ↗
Acting FDA Chief Meets Rare Disease Groups to Repair Relations
Read more ↗
Alnylam and Inceptive Sign AI Drug Discovery Deal Worth Up to $2 Billion
Read more ↗
FDA Reviews AI Tool Designed to Predict Drug-Related Liver Damage
Read more ↗
GLP-1 Drugs May Offer Benefits Across Multiple Types of Cancer
Read more ↗
Judge Allows States' Lawsuit Challenging Transgender-Care Probes to Move Forward
Read more ↗
Judge Blocks Florida's Lawsuit Against Group Supporting Transgender Youth Care
Read more ↗
Lilly Cuts Planned Germany Investment by Half
Read more ↗
Lilly Licenses Gene-Editing Technology for Kidney Disease Research
Read more ↗
Medline Receives Second FDA Warning in Two Months Over Quality Issues
Read more ↗
Radiation-Emitting Implant Improves Outcomes After Brain Cancer Surgery
Read more ↗
Unconfirmed U.S. Screwworm Case Shakes Cattle Markets
Read more ↗
U.S. Ebola Team Arrives in Kenya Despite Court Order and Protests
Read more ↗
Abivax Shares Sink After Bowel Disease Drug Results
Read more ↗
CDC Warns About Risks of Getting Cosmetic Surgery Abroad
Read more ↗
Celcuity Shares Plunge After Breast Cancer Trial Results Disappoint
Read more ↗
FDA Rejects Cingulate's ADHD Drug Application
Read more ↗
FDA Wants to Speed Up Gene Therapy Development
Read more ↗
Fulcrum Scraps Sickle Cell Drug Program After FDA Cancer-Risk Concerns
Read more ↗
Health Experts Oppose U.S. Plan to Treat Ebola-Exposed Americans Overseas
Read more ↗
Kenya Defends Planned U.S.-Backed Ebola Quarantine Facility
Read more ↗
Praxis Epilepsy Drug Misses Main Goal in Clinical Trial
Read more ↗
Travere Signs $1.14 Billion Kidney Disease Drug Deal
Read more ↗
U.S. Issues New Guidance for Medicaid Work Requirements
Read more ↗
U.S. May Appoint a Dedicated Ebola Response Coordinator
Read more ↗
U.S. May Re-Engage With Global Vaccine Alliance Gavi
Read more ↗
West Pharmaceutical Appoints New CEO
Read more ↗
Edgewise to Sell Muscle-Dystrophy Business to Servier for Up to $2.65 Billion
Read more ↗
Haisco and Lilly Sign Collaboration and Licensing Deals
Read more ↗
Hundreds Protest Planned U.S. Ebola Quarantine Facility in Kenya
Read more ↗
Merck Discussing Use of COVID Antiviral Drug in Ebola Response
Read more ↗
Moderna Partners to Develop Vaccine for Bundibugyo Ebola Strain
Read more ↗
U.S. Approves Oral Drug to Help Prevent COVID-19
Read more ↗
UnitedHealthcare to Remove Prior Authorization Requirements for Nearly Two-Thirds of Services
Read more ↗
U.S. Court Overturns $452 Million Trade Secret Verdict Against Insulet
Read more ↗
U.S., Mexico and Canada Announce Ebola Travel Measures Ahead of World Cup
Read more ↗
WHO Chief Heads to Congo as Ebola Outbreak Strains Response
Read more ↗
Bristol Myers Drug Delays Progression of Hard-to-Treat Multiple Myeloma
Read more ↗
FDA Advisers Weigh Composition of COVID Vaccines for 2026–2027
Read more ↗
FDA Approves MannKind’s Inhaled Insulin for Children
Read more ↗
Johnson & Johnson Defeats Heart Pump Patent Claims
Read more ↗
Lilly’s Mounjaro Outperforms Other GLP-1 Drugs in Some Diabetes Patients
Read more ↗
Massachusetts Sues UnitedHealth Unit for Allegedly Defrauding Medicaid
Read more ↗
Replimune Reaches Agreement With FDA to Resubmit Melanoma Drug Application
Read more ↗
Amazon Puts Amwell Co-Founder in Charge of Healthcare Unit
Read more ↗
Americans Are Dropping Out of Obamacare Plans
Read more ↗
California Sues 23andMe Over 2023 Data Breach
Read more ↗
CVS Restores Coverage for Lilly’s Obesity Drug Zepbound
Read more ↗
CVS, Walgreens and Walmart Defeat Florida Hospital Opioid Lawsuit
Read more ↗
FDA Advisers Vote in Favor of Updating COVID Vaccines for XFG Variant
Read more ↗
U.S. HHS Finalizes Rule to Streamline “No Surprises Act” Disputes
Read more ↗
Apogee Secures Up to $1.3 Billion From Blackstone to Advance Eczema Drug
Read more ↗
Blood Test Added to U.S. Colorectal Cancer Screening Options
Read more ↗
Cardiovascular Drug Developer Kardigan Files for U.S. IPO
Read more ↗
Insulet Flags Dosing Defect in Some Omnipod Devices
Read more ↗
Rubio Says U.S. Cannot Allow Any Ebola Cases to Enter Country
Read more ↗
U.S. Sets Up Quarantine Facility in Kenya for Americans Exposed to Ebola
Read more ↗
Veracyte Test Identifies Breast Cancer Patients Who Can Skip Chemotherapy
Read more ↗
Zuckerberg Philanthropic Venture Unveils AI “World Model” for Drug Discovery
Read more ↗
Alabama Warns Healthcare Providers Against Non-FDA-Approved Peptides
Read more ↗
Lilly to Buy Three Vaccine Developers for Nearly $4 Billion
Read more ↗
Big Tobacco Comes Out on Top After FDA Shake-Up
Read more ↗
Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market
Read more ↗
FDA Advisers to Weigh Updating 2026–27 COVID Vaccines for XFG Variant
Read more ↗
WHO Warns Ebola Outbreak Is Outpacing Response Efforts
Read more ↗
U.S. Adds Atlanta-Area Airport for Ebola Screening
Read more ↗
U.S. Extends Ebola Travel Ban to Green-Card Holders
Read more ↗
Early Childhood Screening for Type 1 Diabetes May Benefit Patients
Read more ↗FDA Approves Gilead Drug for Deadly Liver Infection
Read more ↗
U.S. HHS Launches AI Initiative to Detect Fraud and Waste in Health Programs
Read more ↗
Minnesota Nonprofit Leader Sentenced to 41 Years in $250 Million Fraud Scheme
Read more ↗
Meta Settles First U.S. Case Over School Costs Linked to Youth Mental Health
Read more ↗
Lilly Says Patients Lost 28% of Body Weight on Next-Generation Obesity Drug
Read more ↗
FDA to Hold Expert Committee Meeting on Moderna Flu Vaccine
Read more ↗
Families Consider Moving States to Preserve Access to Gender-Affirming Care
Read more ↗
Ebola Cases Rise; Returning Americans Must Enter Through Washington Dulles Airport
Read more ↗
U.S. Senator Durbin Urges RFK Jr. Not to Ease Vape Rules
Read more ↗
U.S. Health Secretary Kennedy Fires Members of Key Preventive Health Panel
Read more ↗
U.S. Doctor Exposed to Ebola to Be Hospitalized in Czech Republic
Read more ↗
Pfizer’s Pneumococcal Vaccine Shows Strong Mid-Stage Trial Results
Read more ↗
Medtronic Plans $650 Million Acquisition of SPR Therapeutics
Read more ↗
Court Allows Rhode Island Hospital to Release Transgender Care Records to Texas
Read more ↗
Common Asthma Drug May Improve Cancer Immunotherapy Performance
Read more ↗
Bristol Myers Using Anthropic’s Claude AI to Speed Drug Discovery
Read more ↗
Healthcare AI Firm Commure Valued at $7 Billion After New Funding
Read more ↗
Nestlé and Danone Face Scrutiny Over Baby Formula Recalls
Read more ↗
Takeda Found Guilty of Delaying Cheaper Generic Drug Competition
Read more ↗
Trump Says TrumpRx Will Carry 600 Generic Drugs
Read more ↗
Jury Finds Takeda Delayed Generic Constipation Drug Competition
Read more ↗
Trump Plans Expansion of Discount Drug Pricing Program
Read more ↗
UnitedHealth Falls After Berkshire Hathaway Sells Stake
Read more ↗U.S. Health Department Withdraws Vaccine Advisory Panel Charter
Read more ↗
U.S. Moves to Curb Ebola Risk, Says Immediate Public Risk Is Low
Read more ↗
U.S. Supreme Court Rejects Pharma Challenge to Drug Price Negotiation Law
Read more ↗
Adult Dies From Hantavirus in Colorado
Read more ↗
Boston Scientific Invests $1.5 Billion in Heart Valve Company Mirus
Read more ↗CDC Says One American Tested Positive for Ebola
Read more ↗
Elliott Builds Major Stake in Bio-Rad Laboratories
Read more ↗
Flawed Tests and Funeral Practices Allowed Ebola Spread Undetected
Read more ↗
Acting CDC Chief Says White House Receiving Daily Hantavirus Updates
Read more ↗
Common ADHD Medicines May Help Treat Cancer-Related Fatigue
Read more ↗
Deadline Passes for Supreme Court Extension on Abortion Pill Mail Access
Read more ↗FDA Drug Center Head Expected to Leave Agency
Read more ↗Hantavirus Outbreak Tests Post-COVID Public Health Communication
Read more ↗
Texas Hospital to Launch Youth “Detransition” Clinic After State Investigation
Read more ↗
U.S. CDC Monitoring Ebola Outbreak in Africa
Read more ↗
U.S. Moves to End Job Protections for Hundreds of Health Department Workers
Read more ↗
WHO Warns Nicotine Pouches Could Increase Youth Addiction
Read more ↗
CVS Unit Omnicare Wins Court Approval to Sell Genierx
Read more ↗
U.S. Cancer Clinics Rush to Access Experimental Pancreatic Cancer Drug
Read more ↗
U.S. Judge Blocks Justice Department Attempt to Restrict Rhode Island Hospital’s Transgender Care
Read more ↗
Easing Medical Costs Help Health Insurers But Bigger Risks Remain
Read more ↗
Eli Lilly Launches Alzheimer’s Drug Donanemab in India
Read more ↗
KKR-Backed Ambulance Giant GMR Raises $478.7 Million in U.S. IPO
Read more ↗
U.S. Defers $1.3 Billion Medicaid Funds to California
Read more ↗
U.S. Halts Medicare Enrollment for New Home Healthcare and Hospice Providers
Read more ↗
Google-Backed Isomorphic Raises $2.1 Billion for AI Drug Discovery
Read more ↗
Hims & Hers Raises 2026 Revenue Forecast
Read more ↗
Hims & Hers Shares Fall After Weight-Loss Strategy Hurts Quarterly Results
Read more ↗
New York Hospital System Receives Grand Jury Subpoena in Transgender Care Probe
Read more ↗
OpenAI Faces Lawsuit Over Alleged Harmful Chatbot Advice
Read more ↗
Steris Forecasts Strong Profit on Procedure Demand
Read more ↗
Prison Health Company YesCare Lost 80% Revenue After Malpractice Verdict
Read more ↗Hims & Hers Raises 2026 Revenue Forecast on Strong Subscriber Growth
Read more ↗Lilly Halts India Obesity Awareness Campaign After Regulatory Scrutiny
Read more ↗Amazon to Sell Ozempic Through U.S. Kiosks With Same-Day Delivery
Read more ↗
Italy’s Angelini Pharma to Buy U.S. Catalyst Pharma in $4.1 Billion Deal
Read more ↗
State Attorneys General Increase Antitrust and Consumer Protection Enforcement
Read more ↗
Cencora Raises Annual Profit Forecast Despite Quarterly Miss
Read more ↗
CVS Health Raises 2026 Forecast After Improving Medical Cost Controls
Read more ↗
DaVita Lifts Annual Profit Forecast on Strong Dialysis Demand
Read more ↗
Healthcare Affordability Becomes Top Concern for U.S. Voters
Read more ↗
CVS to drop Johnson & Johnson’s Stelara from key drug lists
Read more ↗
HIV prevention uptake rises but coverage gaps remain
Read more ↗
Pfizer Beats Profit Estimates on Strong Eliquis Demand
Read more ↗
UnitedHealthcare Removes Prior Authorization for 30% of Services
Read more ↗
U.S. drug pricing deal projected to save $64.3 billion
Read more ↗
Viridian Therapeutics eye disease drug succeeds in late-stage trial
Read more ↗
Weight-loss drug boom drives surge in protein demand
Read more ↗
Emergency medical services provider GMR files for U.S. IPO
Read more ↗
GLP-1 weight-loss boom drives demand for aesthetic procedures
Read more ↗
Mirum Pharmaceuticals mid-stage liver disease drug succeeds
Read more ↗
Odyssey Therapeutics files for U.S. IPO
Read more ↗
U.S. Health Secretary pushes for fast policy wins ahead of elections
Read more ↗
U.S. Supreme Court temporarily restores access to abortion pill via telemedicine
Read more ↗
Universal Health Services beats estimates but flags pressure
Read more ↗
Moderna cuts forecast amid declining COVID vaccine demand
Read more ↗
Medicare portal data breach exposes provider Social Security numbers
Read more ↗
Medicare Advantage plans may cut extra benefits in 2027
Read more ↗
CVS Health beats estimates as medical costs stabilize
Read more ↗
Amgen weight-loss drug shows promising early results
Read more ↗
Merck beats sales estimates on strong cancer drug demand
Read more ↗
FDA proposes restricting compounded weight-loss drugs
Read more ↗
Eli Lilly raises forecast on continued GLP-1 demand
Read more ↗
Cigna raises profit forecast and exits ACA marketplace
Read more ↗
Cardinal Health raises profit forecast on specialty drug demand
Read more ↗
Baxter beats estimates on strong demand for medical products
Read more ↗
Eli Lilly investors focus on obesity pill launch performance
Read more ↗
CMS extends deadlines for Medicaid drug pricing model
Read more ↗
U.S. seeks new nominees for key preventive health panel
Read more ↗
Regeneron Pharmaceuticals beats estimates on strong drug demand
Read more ↗
Pfizer cancer drug succeeds in late-stage trial
Read more ↗
Humana beats estimates but signals Medicare pressure
Read more ↗
GE HealthCare cuts profit forecast due to inflation
Read more ↗
Boston Scientific procedure outperforms drugs for heart rhythm disorder
Read more ↗
AbbVie beats estimates as new drugs offset Humira decline
Read more ↗
Centene raises profit forecast on improving cost control
Read more ↗
Eli Lilly signs $2.25B genetic medicine AI partnership
Read more ↗FDA leadership transition update
Read more ↗
Incyte beats estimates on strong cancer drug demand
Read more ↗
Pfizer secures deals to delay generic competition
Read more ↗
Purdue Pharma sentencing advances opioid settlement
Read more ↗
Zimmer Biomet signals cautious outlook amid operational changes
Read more ↗
Intellia gene-editing therapy shows strong late-stage results
Read more ↗
South Carolina measles outbreak ends
Read more ↗
Medtronic reports cyberattack on IT systems
Read more ↗
U.S. FDA moves to fast-track psychedelic drugs
Read more ↗
CureVac sues Moderna over COVID-19 vaccine patents
Read more ↗
Type 2 diabetes procedure helps sustain weight loss after GLP-1 drugs
Read more ↗
HCA Healthcare beats profit estimates but signals volume pressure
Read more ↗
Eli Lilly obesity pill sees early prescription uptake
Read more ↗
Health insurers move to standardize prior authorization
Read more ↗
White House, Regeneron drug pricing deal
Read more ↗
U.S. reclassifies marijuana as less dangerous drug
Read more ↗
Regeneron gene therapy approved by FDA
Read more ↗
Medicare’s New RAPID Pathway: Closing the Coverage Gap
Read more ↗
Merck Deal Interest: A Keytruda Ecosystem Expansion Signal
Read more ↗
Actuate Therapeutics Success: An Early-Stage Oncology Signal
Read more ↗
Amneal Pharma Acquisition: A Massive Bet on Biosimilars
Read more ↗
Boston Scientific Cuts Forecast: A Signal of Device Market Pressure
Read more ↗
Elevance Health Raises Profit Forecast: A Margin Recovery Signal
Read more ↗
Medicare Obesity Drug Coverage Delay: A Payer Friction Signal
Read more ↗
Hims & Hers Expands into Menopause Care Amid Patch Shortage
Read more ↗
CDC Publication Block: A New Era of Scientific Communication
Read more ↗
UnitedHealth Group Signals Stabilization After Turbulent Period
Read more ↗
Diagnostics Demand Signals Continued Healthcare Utilization
Read more ↗
Vaccine Guidance Disruption Creates Uncertainty in Preventive Care
Read more ↗
Cancer Drug Development Hits Setback in Late-Stage Trial
Read more ↗
Bioprocessing Strength Signals Continued Investment in Drug Development
Read more ↗
The Medicaid Provider Revalidation Push: A System-Level Shift
Read more ↗
Weight-Loss Drugs Are Quietly Reshaping the Cannabis Market
Read more ↗
Psychedelics Are Moving Into Mainstream U.S. Healthcare
Read more ↗YOUR NEXT MOVE
Explore your use case ↗Bring your market into focus.
See how organizations, people, clinical activity and intent come together for your team.